From self-driving cars to ChatGPT and Amazon Bedrock, the world is quickly waking up to the enormous potential for artificial intelligence (AI) to change our world. Much discussion has focused on whether this will ultimately be for better or worse; but as with any seismic shift in technology, the answer will depend on how we choose to engage with and deploy the new tools.
Artificial Intelligence at Clarivate
At Clarivate, our dedicated Data Science team have implemented AI across our portfolio to enhance our tools and solutions for decades, and they are forward thinking in their approach to utilizing new technology as it emerges. By bringing clarity to the complex, we give our customers the confidence to make critical decisions, navigate roadblocks and achieve their potential.
Artificial intelligence tools are just one of the many ways that we augment our products, tools and services. We use generative AI to ensure we provide our customers with the highest quality integrated public and proprietary content and insights, whilst also mitigating any risks involved.
Of course, artificial intelligence can only ever be as good as the input data. At Clarivate we are well-placed to capitalize on this because we have billions of proprietary best-in-class data assets, which are expertly curated and interconnected. These data feed our machine, deep learning and large language models to enrich our information and power our insights, services and workflow solutions.
Artificial Intelligence for our customers
Academia & Government: For example, we use AI to identify academic journals within the Web of Science™ that are outliers, to ensure our customers are confident that they can trust all indexed journals and continue to deliver gold-standard content. Trained machine learning algorithms flag these journals to our in-house editors who conduct a thorough analysis of the journal and whether it meets our standards.
Intellectual Property: Another example is the CompuMark™ Naming Tool which uses generative AI to automate the process of brainstorming new brand names, simultaneously analyzing them for potential usability. Trained on US, EU and Pharma In-Use databases, our proprietary AI algorithm generates creative name suggestions based on your criteria in seconds, simultaneously analyzing them against existing domain names and social media handles.
Life Sciences & Healthcare: A further example is how we draw upon our connected data lakes in Cortellis™ and use machine learning to generate predictors of future success relating to clinical trials progression, regulatory approvals and even valuations on M&A candidates.
How we protect your data from irresponsible use of AI
We have company-wide guidelines on the use of any generative AI application or tool. Due to the rapidly-changing nature of the AI landscape, we will constantly review and evolve these guidelines as technology changes.
We are fiercely protective of data from all sources to ensure the privacy and security of our customers and partners. Our internal approvals process ensures checks and balances before using generative AI with any of our products or services, or before allowing any third party to use our content and products within their use of generative AI.
Thinking forward
Our expertly curated data lays a solid trusted foundation, which is built on through the latest tools and our people’s deep expertise in their subjects, as well as their thorough understanding of the risks involved and what truly matters to our customers, partners, and investors. AI is already deeply embedded in our business at Clarivate, and we will continue to look for ways to enhance our solutions and services using the very latest tools.
As a result, we help our customers to think forward no matter what new technologies emerge, knowing they can rely on our partnership.
For more information on Clarivate and artificial intelligence, read our announcement regarding the launch of our new artificial intelligence tools.
Podcast: How science and big data are helping in the search for an effective treatment of a rare disease that causes blindness. This podcast demonstrates how AI can make a positive difference in the lives of individual patients.